Inspection reports obtained by ABC News show a series of quality control issues. Even as shots of the Johnson & Johnson COVID-19 vaccine resume across the country following a recent ...
The FDA has cleared another batch of up to 15 million doses of Johnson & Johnson’s COVID-19 vaccine made at Emergent BioSolutions’ Baltimore plant, The New York Times reported. The July 2 ...
Two congressional committees have expanded their investigation of the Emergent BioSolutions Baltimore plant where millions of Johnson & Johnson COVID-19 vaccines were thrown out due to possible ...
The company is selling off a variety of manufacturing plants and products in an effort to cut costs. Emergent stock soars as biotech enters ‘turnaround’ phase Emergent will pay $40M to settle ...
The company is selling off a variety of manufacturing plants and products in an effort to cut costs. One of Maryland’s largest biotechnology companies will sell off a Baltimore-area facility for $36.5 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback